Bringing Hope to Improve Treatment in Pancreatic Ductal Adenocarcinoma-A New Tool for Molecular Profiling of <i>KRAS</i> Mutations in Tumor and Plasma Samples.

Cancers (Basel) · 2024 · PMC11506488 · PMID 39456638

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

marginally significantp = 0.054so close (0.05 < p ≤ 0.1)

KRAS mutation status in tumor was marginally significant ( p = 0.054).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.